FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adolf Mistr

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Tumor Cell Line

Disorders

Procedures

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Petr Sova; Adolf Mistr; Ales Kroutil; Martin Semerád; Hana Chlubnová; Veronika Hrusková; Jirina Chládková; Jaroslav Chládek
A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV).
Petr Sova; Adolf Mistr; Ales Kroutil; Frantisek Zak; Pavla Pouckova; Marie Zadinova
Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts.
Petr Sova; Adolf Mistr; Ales Kroutil; Frantisek Zak; Pavla Pouckova; Marie Zadinova
Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adolf Mistr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Petr Sova; Adolf Mistr; Ales Kroutil; Martin Semerád; Hana Chlubnová; Veronika Hrusková; Jirina Chládková; Jaroslav Chládek
A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV).
Cancer chemotherapy and pharmacology 2011;67(6):1247-56.
2006: Petr Sova; Adolf Mistr; Ales Kroutil; Frantisek Zak; Pavla Pouckova; Marie Zadinova
Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts.
Anti-cancer drugs 2006;17(2):201-6.
2005: Petr Sova; Adolf Mistr; Ales Kroutil; Frantisek Zak; Pavla Pouckova; Marie Zadinova
Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12.
Anti-cancer drugs 2005;16(6):653-7.
2005: Alois Kozubík; Viktor Horváth; Lenka Švihálková-Šindlerová; Karel Soucek; Jirina Hofmanová; Petr Sova; Ales Kroutil; Frantisek Zák; Adolf Mistr; Jaroslav Turánek
High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
Biochemical pharmacology 2005;69(3):373-83.
2005: Petr Sova; Jaroslav Chladek; Frantisek Zak; Adolf Mistr; Ales Kroutil; Martin Semerad; Zdenek Slovak
Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)].
International journal of pharmaceutics 2005;288(1):123-9.
2004: Jaroslav Turánek; Andrea Kasná; Dana Záluská; Jirí Neca; Veronika Kvardová; Pavlína Knötigová; Viktor Horváth; Lenka Švihálková-Šindlerová; Alois Kozubík; Petr Sova; Ales Kroutil; Frantisek Zák; Adolf Mistr
New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes.
Anti-cancer drugs 2004;15(5):537-43.
2004: Frantisek Zák; Jaroslav Turánek; Ales Kroutil; Petr Sova; Adolf Mistr; Anna Poulová; Petr Mikolin; Zdirad Zák; Andrea Kasná; Dana Záluská; Jirí Neca; Lenka Švihálková-Šindlerová; Alois Kozubík
Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
Journal of medicinal chemistry 2004;47(3):761-3.